Literature DB >> 16314859

Gaining insight into PTPN22 and autoimmunity.

Peter K Gregersen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314859     DOI: 10.1038/ng1205-1300

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  24 in total

Review 1.  The genetics of systemic lupus erythematosus: understanding how SNPs confer disease susceptibility.

Authors:  Marta E Alarcón-Riquelme
Journal:  Springer Semin Immunopathol       Date:  2006-09-09

2.  Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling.

Authors:  Adrian F Arechiga; Tania Habib; Yantao He; Xian Zhang; Zhong-Yin Zhang; Andrew Funk; Jane H Buckner
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

Review 3.  Molecular mechanisms in autoimmune type 1 diabetes: a critical review.

Authors:  Zhiguo Xie; Christopher Chang; Zhiguang Zhou
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

4.  A biosynthetic pathway for anandamide.

Authors:  Jie Liu; Lei Wang; Judith Harvey-White; Douglas Osei-Hyiaman; Raj Razdan; Qian Gong; Andrew C Chan; Zhifeng Zhou; Bill X Huang; Hee-Yong Kim; George Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

Review 5.  Association of susceptible genetic markers and autoantibodies in rheumatoid arthritis.

Authors:  Vasanth Konda Mohan; Nalini Ganesan; Rajasekhar Gopalakrishnan
Journal:  J Genet       Date:  2014-08       Impact factor: 1.166

6.  Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects.

Authors:  Kai Wang; Robert Baldassano; Haitao Zhang; Hui-Qi Qu; Marcin Imielinski; Subra Kugathasan; Vito Annese; Marla Dubinsky; Jerome I Rotter; Richard K Russell; Jonathan P Bradfield; Patrick M A Sleiman; Joseph T Glessner; Thomas Walters; Cuiping Hou; Cecilia Kim; Edward C Frackelton; Maria Garris; James Doran; Claudio Romano; Carlo Catassi; Johan Van Limbergen; Stephen L Guthery; Lee Denson; David Piccoli; Mark S Silverberg; Charles A Stanley; Dimitri Monos; David C Wilson; Anne Griffiths; Struan F A Grant; Jack Satsangi; Constantin Polychronakos; Hakon Hakonarson
Journal:  Hum Mol Genet       Date:  2010-02-22       Impact factor: 6.150

Review 7.  The environment and the origins of islet autoimmunity and Type 1 diabetes.

Authors:  S Eringsmark Regnéll; A Lernmark
Journal:  Diabet Med       Date:  2013-02       Impact factor: 4.359

8.  Identifying potent, selective protein tyrosine phosphatase inhibitors from a library of Au(I) complexes.

Authors:  Mark R Karver; Divya Krishnamurthy; Rhushikesh A Kulkarni; Nunzio Bottini; Amy M Barrios
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

9.  Integrating virtual and biochemical screening for protein tyrosine phosphatase inhibitor discovery.

Authors:  Katie R Martin; Pooja Narang; José L Medina-Franco; Nathalie Meurice; Jeffrey P MacKeigan
Journal:  Methods       Date:  2013-08-20       Impact factor: 3.608

10.  Evaluation of PTPN22 polymorphisms and Vogt-Koyanagi-Harada disease in Japanese patients.

Authors:  Yukihiro Horie; Nobuyoshi Kitaichi; Yoshihiko Katsuyama; Kazuhiko Yoshida; Toshie Miura; Masao Ota; Yuri Asukata; Hidetoshi Inoko; Nobuhisa Mizuki; Susumu Ishida; Shigeaki Ohno
Journal:  Mol Vis       Date:  2009-06-03       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.